Issuance of Share Acquisition Rights for Officers and Employees
First written in FY2017-Q2. 23 of 24 entries say "Advanced", first in FY2017. Latest entry: FY2027-H1.
- FY2027-H1AdvancedAnnual report
「36th Series of Stock Acquisition Rights Resolution date 12 May 2026 (Annual General Meeting of Shareholders) Eligible recipients and number of recipients 98 employees of the Company Number of stock acquisition rights (units)* 1,322 (Note 1) Class, terms and number of shares underlying the stock acquisition rights (shares)* Common shares: 132,200 (Note 1) Exercise period for the stock acquisition rights* 1 June 2028 to 31 May 2030」
The Company issued 1,322 36th Series stock acquisition rights to 98 employees, covering 132,200 shares, with an exercise period from 1 June 2028 to 31 May 2030. - FY2026-H1AdvancedAnnual report
「The Series 34 Stock Acquisition Rights cover 2,000 common shares, while the Series 35 Stock Acquisition Rights cover 114,600 common shares. The exercise period for both series is 1 June 2027–31 May 2030.」
The filing records the Series 34 Stock Acquisition Rights issued on 2 June 2025 as covering 2,000 shares for 1 director, and the Series 35 Stock Acquisition Rights as covering 114,600 shares for 89 employees. - FY2025AdvancedAnnual report
「The Series 34 Stock Acquisition Rights cover 20,000 common shares, while the Series 35 Stock Acquisition Rights cover 200,000 common shares. The exercise period for both series is 1 June 2027–31 May 2030.」
Following the resolution of 13 May 2025, new Stock Acquisition Rights grant pools were established covering up to 20,000 shares for directors and 200,000 shares for employees. - FY2025-H1AdvancedAnnual report
「Series 33 Stock Acquisition Rights Categories and number of eligible persons 56 employees of the Company Number of Stock Acquisition Rights (rights)* 756 (Note 1) Class, details and number of shares underlying the Stock Acquisition Rights (shares)* Common shares 75,600 (Note 1) Exercise period for the Stock Acquisition Rights* 1 June 2026–31 May 2030」
The filing records the issuance of 756 rights covering 75,600 shares to 56 employees under the Series 33 Stock Acquisition Rights. The exercise period is from 1 June 2026 to 31 May 2030. - FY2024AdvancedAnnual report
「Series 33 Stock Acquisition Rights Resolution date 14 May 2024 (Annual General Meeting of Shareholders) Number of Stock Acquisition Rights (rights) 2,000 Class, details and number of shares underlying the Stock Acquisition Rights (shares) Common shares 200,000 Exercise period for the Stock Acquisition Rights 1 June 2026–31 May 2030」
A new grant pool for the Series 33 Stock Acquisition Rights was established for employees, covering up to 200,000 common shares. - FY2024-Q2AdvancedAnnual report
「The Series 31 Stock Acquisition Rights represent 122,000 common shares and the Series 32 Stock Acquisition Rights represent 1,205,700 common shares. The exercise period for both is from 1 June 2025 to 31 May 2030.」
It is reported that Series 31 Stock Acquisition Rights representing 122,000 shares were actually issued to 5 directors and Series 32 Stock Acquisition Rights representing 1,205,700 shares were issued to 596 employees on 5 June 2023. - FY2023AdvancedAnnual report
「Series 31 Stock Acquisition Rights Number of stock acquisition rights (units) 2,000 Class, description and number of shares underlying the stock acquisition rights (shares) Common shares 200,000 Exercise period for the stock acquisition rights 1 June 2025–31 May 2030 Series 32 Stock Acquisition Rights Number of stock acquisition rights (units) 15,000 Class, description and number of shares underlying the stock acquisition rights (shares) Common shares 1,500,000 Exercise period for the stock acquisition rights 1 June 2025–31 May 2030」
Pursuant to the resolution of the annual general meeting of shareholders held on 16 May 2023, new Stock Acquisition Rights allocation limits were established at 200,000 shares for directors and 1,500,000 shares for employees. - FY2023-Q2AdvancedAnnual report
「Series 30 Stock Acquisition Rights Resolution date 17 May 2022 (annual general meeting of shareholders) Category and number of persons eligible for grants 89 employees of the Company Number of stock acquisition rights (units)* 887 (Note) 1 Class, description and number of shares underlying the stock acquisition rights (shares)* Common shares 88,700 (Note) 1 Exercise period for the stock acquisition rights* 1 June 2024–31 May 2025」
It is reported that 887 Series 30 Stock Acquisition Rights representing 88,700 underlying shares were issued to 89 employees on 6 June 2022. - FY2022AdvancedAnnual report
「Series 30 Stock Acquisition Rights Resolution date 17 May 2022 (annual general meeting of shareholders) Category and number of persons eligible for grants Employees of the Company designated by the Board of Directors Number of stock acquisition rights (units) 2,000 Class, description and number of shares underlying the stock acquisition rights (shares) Common shares 200,000 Exercise period for the stock acquisition rights 1 June 2024–31 May 2025」
A new allocation limit of 200,000 shares for one year was established for the Series 30 Stock Acquisition Rights for employees. - FY2022-Q2AdvancedAnnual report
「Series 28 Stock Acquisition Rights Category and number of persons eligible for grants 3 directors of the Company (excluding directors who are Audit and Supervisory Committee members) Class, description and number of shares underlying the stock acquisition rights (shares)* Common shares 12,000 (Note) 1 Exercise period for the stock acquisition rights* 1 June 2023–31 May 2025 Series 29 Stock Acquisition Rights Category and number of persons eligible for grants 91 employees of the Company Class, description and number of shares underlying the stock acquisition rights (shares)* Common shares 84,000 (Note) 1 Exercise period for the stock acquisition rights* 1 June 2023–31 May 2025」
The Company reports the issuance on 7 June 2021 of Series 28 Stock Acquisition Rights representing 12,000 shares to 3 directors and Series 29 Stock Acquisition Rights representing 84,000 shares to 91 employees. - FY2021AdvancedAnnual report
「Series 28 Stock Acquisition Rights Resolution date 18 May 2021 (annual general meeting of shareholders) Number of stock acquisition rights (units) 200 Class, description and number of shares underlying the stock acquisition rights (shares) Common shares 20,000 Series 29 Stock Acquisition Rights Resolution date 18 May 2021 (annual general meeting of shareholders) Number of stock acquisition rights (units) 2,000 Class, description and number of shares underlying the stock acquisition rights (shares) Common shares 200,000」
New allocation limits were established for the Series 28 and Series 29 Stock Acquisition Rights, capped at 20,000 shares for directors and 200,000 shares for employees, respectively. - FY2021-Q2AdvancedAnnual report
「Series 26 Stock Acquisition Rights Category and number of persons eligible for grants 1 director of the Company Class, description and number of shares underlying the stock acquisition rights (shares)* Common shares 10,000 (Note) 1 Exercise period for the stock acquisition rights* 1 June 2022–31 May 2025 Series 27 Stock Acquisition Rights Category and number of persons eligible for grants 99 employees of the Company Class, description and number of shares underlying the stock acquisition rights (shares)* Common shares 120,500 (Note) 1 Exercise period for the stock acquisition rights* 1 June 2022–31 May 2025」
It is reported that the Company actually issued Series 26 Stock Acquisition Rights representing 10,000 shares to 1 director and Series 27 Stock Acquisition Rights representing 120,500 shares to 99 employees, both issued on 2 June 2020. - FY2020AdvancedAnnual report
「Series 26 Stock Acquisition Rights Resolution date 12 May 2020 (annual general meeting of shareholders) Category and number of persons eligible for grants Directors of the Company designated by the Board of Directors Number of stock acquisition rights (units) 100 Class, description and number of shares underlying the stock acquisition rights (shares) Common shares 10,000 Exercise period for the stock acquisition rights 1 June 2022–31 May 2025」
New allocation limits were established for the Series 26 and Series 27 Stock Acquisition Rights, capped at 10,000 shares for directors and 200,000 shares for employees, respectively. - FY2020-Q2AdvancedAnnual report
「Category and number of persons eligible for grants 2 directors of the Company Number of stock acquisition rights (units)* 120 (Note) 1 Class, description and number of shares underlying the stock acquisition rights (shares)* Common shares 12,000 (Note) 1」
The Company issued 120 Series 24 Stock Acquisition Rights representing 12,000 underlying shares to 2 directors and 1,032 Series 25 Stock Acquisition Rights representing 103,200 underlying shares to 98 employees. The exercise period for both is from 1 June 2021 to 31 May 2025. - FY2019AdvancedAnnual report
「The total limit is 200,000 shares for one year.」
New allocation limits were established for the Series 24 and Series 25 Stock Acquisition Rights, capped at 20,000 shares for directors and 200,000 shares for employees, respectively, with an exercise period from 1 June 2021 to 31 May 2025. - FY2019-Q2AdvancedAnnual report
「The stock acquisition rights issued during the current second quarter accounting period are as follows: the Series 22 Stock Acquisition Rights comprise 1,260 units, representing 126,000 underlying shares, and the Series 23 Stock Acquisition Rights comprise 9,991 units, representing 999,100 underlying shares. The exercise period for both is from 1 June 2020 to 31 May 2025.」
The actual number of Series 22 and Series 23 Stock Acquisition Rights issued and their exercise periods are reported as 126,000 shares for directors and 999,100 shares for directors and employees, respectively. - FY2018AdvancedAnnual report
「The total limit is 200,000 shares for one year.」
A new annual limit of 200,000 shares for directors under the Series 22 Stock Acquisition Rights is additionally reported, along with a limit of 1,500,000 shares for employees under the Series 23 Stock Acquisition Rights. - FY2018-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter are as follows.」
The Company issued 20 Series 20 Stock Acquisition Rights representing 2,000 underlying shares and 1,430 Series 21 Stock Acquisition Rights representing 143,000 underlying shares. The exercise period for both is from 1 June 2019 to 31 May 2020. - FY2017AdvancedAnnual report
「16 May 2017 (annual general meeting of shareholders) Directors of the Company designated by the Board of Directors 2,000 (Note) 1 1 June 2019–31 May 2020」
The resolution details specify an annual limit of 2,000 shares for directors under the Series 20 Stock Acquisition Rights and a limit of 220,000 shares for employees under the Series 21 Stock Acquisition Rights. - FY2017-Q2First statedAnnual report
「The stock acquisition rights issued during the current second quarter accounting period are as follows: Series 18 Stock Acquisition Rights and Series 19 Stock Acquisition Rights. The Series 18 Stock Acquisition Rights comprise 30 units, representing 3,000 underlying shares, and the Series 19 Stock Acquisition Rights comprise 2,356 units, representing 235,600 underlying shares. The exercise period for both is from 1 June 2018 to 31 May 2020.」
The Series 18 and Series 19 Stock Acquisition Rights were issued pursuant to the resolution of the annual general meeting of shareholders held on 17 May 2016, with exercise conditions and exercise periods established for directors, employees and others.